Korean Market
PERI
LivsMed
★★

LivsMed Q1 2026 Revenue Up 5.5% YoY, Net Loss Improves, Cash Holdings at 16.4B KRW

 
MATR
LivsMed
★

Disclosure of Decision to Acquire Tangible Assets without Specific Details